| Literature DB >> 31354188 |
Eman M M Abdelraheem1,2, Shabnam Shaabani1, Alexander Dömling1.
Abstract
Artificial macrocycles recently became popular as a novel research field in drug discovery. As opposed to their natural twins, artificial macrocycles promise to have better control on synthesizability and control over their physicochemical properties resulting in druglike properties. Very few synthetic methods allow for the convergent, fast but diverse access to large macrocycles chemical space. One synthetic technology to access artificial macrocycles with potential biological activity, multico<span class="Gene">mponent reactions, is reviewed here, with a focus on our own work. We believe that synthetic chemists have to acquaint themselves more with structure and activity to leverage the design aclass="Chemical">spect of their daily work.Entities:
Keywords: bioactivity; bioavailability; convergence; druglike properties; macrocycle; multicomponent reaction; property space; synthetic pathway
Year: 2018 PMID: 31354188 PMCID: PMC6660156 DOI: 10.1055/s-0036-1591975
Source DB: PubMed Journal: Synlett ISSN: 0936-5214 Impact factor: 2.454